Diabetes Compound from Dr. Reddy’s Found Successful in Phase III Study

by Thilaka Ravi on  January 06, 2010 at 2:18 PM Diabetes News
  •   Print
  •   Share
  •   Comments
  •  Text 
India-based drug maker Dr. Reddy’s Laboratories and a subsidiary of Nordic Bioscience, Rheoscience, announced the success of a diabetic compound from the first phase III study. According to the study, their investigational agent, Balaglitazone, a diabetes compound was successful in the trial, meeting the study’s primary endpoint of reduction in HbA1c.

The study was a randomized, double blind, parallel-group placebo- and active comparator-controlled clinical study to determine how effective and safe the diabetic compound Balaglitazone was, in usage. The study explored the impact of adding placebo, Balaglitazone 10mg, Balaglitazone 20mg or Pioglitazone 45mg to a background treatment regimen of stable insulin therapy for a period of 26 weeks. While the primary endpoint was HbA1c reduction, there were various secondary endpoints including fasting plasma glucose, edema, weight gain, and body composition.

The study had 409 patients randomized in roughly equal proportions across the four arms of the study. All three active arms (Balaglitazone 10mg, 20mg and Pioglitazone 45mg) showed levels of efficacy that were alike for HbA1c and fasting plasma glucose.

 All three active arms demonstrated good tolerability and adverse event profile, with Balaglitazone 10mg showing less water retention, less fat accumulation, lower weight/BMI gain and less bone loss in comparison to the Pioglitazone arm. Adverse events were similar in number across the three active arms, with adverse events of special interest such as bone fracture, hematuria, heart failure, cardiac ischemia, oedema, weight gain, being less in number in the Balaglitazone 10mg group compared to Pioglitazone 45mg.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.

kinggill(Guest)

01/06/2010

I am diabetic from 18 years and more - excersice jogging and diet intake made me live that long- how this will help someone like me . please be very clear




X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Diabetes
Are you at risk for diabetes? To find out check out our health quiz.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Diabetes
Complete Medindia Resources
News Categories:  
Senior Health Center

Diabetes Related News

» Severity of Sleep Apnea Could Predict Diabetes » Proper Care Can Prevent Amputations in Diabetic Foot Infections
» ACE2, Protective Molecule Champions in Diabetic Patients » Bariatric Surgery can Lower Blood Sugar Levels
» Researchers Discover Target for Diabetes Drug » Diabetes Cases Could Rise by 64 Percent in the US by 2025
» Cut-Rate Paper-Based Diabetes Test Apt for Developing Countries » Medication Errors Put Diabetics Lives at Risk: Report
Read More >>